|Limited Submission Programs - Cancer Prevention and Research Institute of Texas (CPRIT): Bridging the Gap: Early Translational Research Awards (ETRA) [PDF]|
|Funding Agency Deadline||08/07/14 by 3 p.m. CST|
|Funding or Award Criteria||
Program Description: CPRIT fosters cancer research in Texas by providing financial support for a wide variety of projects relevant to cancer research. This Request for Applications (RFA) solicits applications for research projects addressing critically important needs related to the diagnosis, prevention, and/or treatment of cancer. The objective of this award is to “bridge the gap” between promising new discoveries achieved in the research laboratory and commercial development by funding advancement toward investigational new drug (IND) clearance or investigational device exemption (IDE) approval (See Section 3, Mechanism of Support) for the therapeutic, device, or diagnostic assay through activities up to and including preclinical proof-of-principle data that demonstrate applicability to the planned clinical scenario. The work funded under this RFA must be deemed sufficiently robust such that successful completion would result in identification of a “lead” compound, assay, or device that, as a next stage, could be taken into full development in compliance with International Conference on Harmonization (ICH) Guidelines and U.S. regulatory guidance documents and regulations. Applicants must identify a clear path of development consistent with the Target Product Profile outlined in the application. Any not-for-profit institution that conducts research is eligible to apply for funding under this award mechanism; a public or private company is not eligible.
Please see the solicitation for complete information.
|Number of Nominees Allowed||Four (4) proposals from The University of Texas at Austin|
|Required Internal Review Documents||
Qualified Applicants should submit the following materials electronically to email@example.com by 4:30 p.m. on Friday, June 13, 2014:
|Nominee(s) Selected to Advance||
Dr. Zhengrong Cui, College of Pharmacy
Dr. George Georgiou, Cockrell School of Engineering
Dr. Thomas Milner, Cockrell School of Engineering
Dr. Jonathan Sessler, College of Natural Sciences